Archive for March, 2021
- PlantX Life welcomes new brand ambassadors Venus Williams and Alicia Silverstone
- Plant-based lifestyle allowed Williams to “continue her dreams” as a world-renowned tennis player
- Silverstone chose plant-based two decades ago, calling it “just a healthier way to be”
PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) has announced world-renowned tennis player Venus Williams and well-known actress Alicia Silverstone as brand ambassadors for the company — a company that Williams noted is “long overdue.”
“I can’t tell you how excited I am to be involved, an ambassador, a cheerleader, a stakeholder, and all the above, in PlantX,” said Williams following the announcement, which was made during the company’s annual general meeting (https://ibn.fm/lVSOG). “It’s the first market of its kind, and it’s long overdue.”
A former number 1-ranked tennis player with four Olympic gold medals and seven Grand Slam singles titles to her name, Williams first became involved in a plant-based lifestyle 10 years ago when she was diagnosed with an autoimmune disease that threatened to derail her tennis career. At the suggestion of her sister Serena, also a world champion tennis player, Williams committed to a three-week, all-raw vegan program and saw immediate results.
“That was my introduction,” she said. “Not only did I learn a lot about food but the food system, and how it fills your body and how we have strayed so far away from where we started as humans and to where we are right now.”
Williams noted that a plant-based lifestyle has “become my passion and my hobby, and it’s been able to help me not only get back on tour but also to live a much better quality of life, because when you have a chronic illness, your quality of life goes down. To be able to live a much better quality of life was obviously the first step, and then to be able to continue to live my dreams was the second step.”
Silverstone noted similar health benefits when she adopted her vegan lifestyle 20 years ago before many people were even familiar with it, she said, speaking about her enthusiasm for PlantX and her role as a brand ambassador for the Company. Although her primary motivation for choosing a plant-based diet was because she loved animals, she suffered from allergies and wanted to lose weight.
“I took on this new way of eating, and I ditched all of that,” she said. “My asthma inhaler went away, my allergy shots went away, my body started to slim down, and this was all by accident. I just did it because I didn’t want to be mean to my dog anymore. . . I made the change but all these amazing health things began to happen. As I did research and started to look at all these studies, it just shows [plant-based] is just a healthier way to be.”
Since her decision, Silverstone has become an outspoken advocate for health and wellness, with a particular interest in and support for the plant-based lifestyle.
Silverstone and Williams have high praise for PlantX Life, a company that is pioneering its path in the plant-based space. As the digital face of the plant-based community, PlantX’s platform is the one-stop shop for everything plant-based. With its fast-growing category verticals, the Company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, PlantX currently has plans to expand its product lines to include cosmetics, clothing and its own water brand.
In addition, the Company uses its digital platform to build a community of like-minded consumers and to provide education. Its successful enterprise is being built and fortified through partnerships with top nutritionists, chefs and brands. For example, the company offers 20 unique pre-made meals designed by top chefs and nutritionists. These healthy meals are offered at extremely competitive prices with fast shipping and round-the-clock convenience.
The Company’s commitment to customer service is the driving force behind its e-commerce platform, with innovative thinking driving its operation; the PlantX team is constantly envisioning new ways to collaborate with local restaurateurs and entrepreneurs to bring PlantX to the world. PlantX is committed to eliminating the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life.
For more information, visit www.PlantX.com, www.PlantX.ca and www.Investor.PlantX.com and view the PlantX for Plant-Based Investors.
NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
Researchers at Spain’s University of Valladolid, BIOFORGE Labs, the SFI Research Center and CÚRAM have created a hydrogel injectable that may prevent additional damage and assist in repairing heart muscles following a heart attack.
Heart disease, or myocardial infarction, is the most common cause of death owing to irreversible damage of cardiac tissue after a heart attack. As tissue regeneration is minimal, any damage to heart muscle can’t be self-repaired. Present-day treatments lack an efficacious way to improve heart muscle repair and prevent death after a heart attack.
The project’s lead, Professor Abhay Pandit, scientific director of CÚRAM, explained that the study involved the testing and development of a hydrogel that had been extracted from a biomaterial that occurs naturally in humans. The elastin-based hydrogel was developed by BIOFORGE-UVa on a quest for advanced hydrogels to be used in regenerative medicine.
He added that the hydrogel was designed to imitate the environment around the heart after tissue death and then customized to be able to boost regeneration of cardiac tissue while also protecting it from further damage.
In the first-ever preclinical study, researchers evaluated the hydrogel injection’s therapeutic effects on cardiac tissue, showing its effectiveness for heart muscle repair after a heart attack. This group of researchers, which was made up of researchers from Italy, Ireland, France, Sweden and Spain, was able to demonstrate that the hydrogel being injected into cardiac tissue following a heart attack resulted in less scarring of heart muscle and an improvement in blood vessel generation in the area. The researchers also observed an increase in the survival and preservation of cardiomyocytes, which are cells that allow the heart to pump in the area that had been affected.
Pandit noted that the project showed the effectiveness of a biomaterial system being able to cause a positive healing effect on heart muscle after a heart attack. He explained that the benefits attained by the well-timed hydrogel injection highlighted and supported the possible use of this treatment, with the next stage being to design a prototype for a hydrogel delivery system.
The study’s senior co-author and a cardiothoracic surgeon, Prof. Mark Da Costa, stated that the scar tissue that formed following a heart attack usually repaired itself in a negative way, which caused issues such as heart failure. He remarked that the hydrogel injection changed how the cardiac tissue healed following a heart attack event, adding that researchers would now focus on methods of delivering the injection to injury sites before moving on to a clinical trial. The researchers’ findings were reported in the “Science Translational Medicine” journal.
Meanwhile, many studies have linked exposure to chemical pesticides to an increased risk of developing heart disease, the effects of which the hydrogel injection could alleviate. To mitigate these adverse effects of chemical use in agriculture, MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) develops natural plant-protection solutions from the mustard plant in order to reduce the need for synthetic substances in the agricultural sector.
NOTE TO INVESTORS: The latest news and updates relating to MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) are available in the company’s newsroom at https://ibn.fm/MGROF
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
MustGrow (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0), an agriculture biotech company focused on providing natural biological protection for high value crops, today announced that it has isolated and concentrated an additional molecule, thiocyanate, from mustard seed. According to the update, thiocyanate is responsible for the systemic activity behind the mustard plant’s natural herbicidal (weed-killer) properties and is the third molecule from mustard seed that MustGrow has isolated, extracted and concentrated. MustGrow had previously announced herbicidal proof-of-concept success without isolating thiocyanate and now expects to build on those studies with identification of this additional herbicidal mode-of-action. MustGrow has commenced greenhouse testing of the new thiocyanate bioherbicide extract, and also in combination with MustGrow’s mustard-based biopesticide TerraMG (active ingredient allyl isothiocyanate (“AITC”)). MustGrow now has two distinct mustard-based natural organic approaches with individual or potential combination applications.
To view the full press release, visit: https://ibn.fm/id58f
About MustGrow Biologics Corp.
MustGrow is a publicly traded agriculture biotech company focused on providing natural science-based biological solutions for high value crops, including fruits, vegetables and other industries. MustGrow has designed and owns a U.S. EPA-approved natural solution that uses the mustard seed’s natural defense mechanism to protect plants from pests and diseases. Over 110 independent tests have been completed, validating MustGrow’s safe and effective signature products. The product, in granule format, is EPA-approved across all key U.S. states and by Health Canada’s Pest Management Regulatory Agency (“PMRA”) as a biopesticide for high value crops such as in fruits and vegetables. MustGrow has now concentrated a mustard extract biopesticide in liquid format, TerraMG, and with regulatory approval, could be applied through standard drip or spray equipment, improving functionality and performance features. In addition, the company’s mustard-derived extract technologies could have other applications in several different industries from pre-plant soil treatment, to weed control, to post harvest disease control and food preservation. The company has approximately 42.0 million basic common shares issued and outstanding and 50.6 million shares fully diluted. For further details please visit www.MustGrow.ca.
NOTE TO INVESTORS: The latest news and updates relating to MGROF are available in the company’s newsroom at http://ibn.fm/MGROF
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
Mohawk Group Holdings’ (NASDAQ: MWK) co-founder and CEO, Yaniv Sarig, recently appeared on DojoLIVE!, a lively podcast and interview forum that brings together a broad roster of technology, business and thought leaders from a wide range of software companies and startups. According to the update, the broadcast, titled “AI and Machine Learning Revolutionize Consumer Packaged Goods,” is available for on-demand viewing on the DojoLIVE! website. During the interview, Sarig discussed ways that AI and machine learning are being used to change consumer packaged goods, particularly in the e-commerce space. “The way consumers shop is dramatically changed online. In traditional brick-and-mortar retail … we had to rely very heavily on what brands told us,” Sarig said during the episode. “What we’re seeing today, if you look at how consumers are shopping in the online retail platforms, they’re actually using data in a very heavy way. They’re doing their own due diligence on products. … A lot of what Mohawk is doing is building a data engine that is trying to understand trends in how consumers are searching for products. … With that data, we can come back and compile a better product that could iteratively grab more market share and, more importantly, better answer customer demand.”
To view the full press release, visit https://ibn.fm/ieQ7D
About Mohawk Group Holdings Inc.
Mohawk Group Holdings, together with its subsidiaries (“Mohawk”), is a rapidly growing technology-enabled consumer products company that uses machine learning, natural language processing and data analytics to design, develop, market and sell products. Mohawk predominantly operates through online retail channels such as Amazon and Walmart. Mohawk has 12 owned and operated brands and sells products in multiple categories, including home and kitchen appliances, kitchenware, environmental appliances (i.e., dehumidifiers and air conditioners), beauty-related products and, to a lesser extent, consumer electronics. Mohawk was founded on the premise that if a company selling consumer packaged goods was founded today, it would apply artificial intelligence and machine learning, the synthesis of massive quantities of data and the use of social proof to validate high-caliber product offerings as opposed to over-reliance on brand value and other traditional marketing tactics. For more information, visit the company’s website at www.MohawkGp.com.
NOTE TO INVESTORS: The latest news and updates relating to MWK are available in the company’s newsroom at http://ibn.fm/MWK
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (“FSA”). HempFusion made the application in conjunction with its strategic and exclusive supply chain partner. The company has now taken the first step in the approval process to obtain approval for products that contain CBD to be sold retail in the UK. The submission requires a detailed analysis of the quality, stability and safety of HempFusion’s raw ingredients as well as other unique product formulations. The company is requesting approval as part of a strategic plan to position itself for continued sales within the UK, which is one of the largest markets in Europe. The company is also preparing to meet anticipated European Union regulations. “We believe the UK’s decision to allow CBD companies to obtain a Novel Food Authorization from the FSA is a tremendous step forward for the global CBD industry,” said HempFusion co-founder and CEO Jason Mitchell in the press release. “HempFusion was built on the pillars of regulatory compliance. We have invested significant time, resources, and energy to ensure our products meet the highest standards, and we are pleased to report our submission includes completed toxicology data, which may represent one of the most complete submissions to date. We look forward to working with the FSA as regulations continue to evolve within the UK. This submission firmly establishes HempFusion as a future leader within the UK market.”
To view the full press release, visit: https://cnw.fm/S8ydO
About HempFusion Wellness Inc.
HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs (“SKUs”) including tinctures, proprietary FDA Drug Listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in store or online. For more information about the company, visit www.HempFusion.com.
NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at http://cnw.fm/HempFusion
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.
A 2020 survey of exploration and resources released last month by the Fraser Institute found the newest attraction for mining investors to be Nevada, which is in the United States. Nevada replaced Western Australia, which is rich in iron ore.
Fraser Institute’s new popular ranking was based on responses collected from 276 participants, which offered adequate data to assess the overall investment attractiveness of 77 regions.
The result is a combination of the Policy Perception Index and the Best Practices Mineral Potential. The former is a composite indicator that measures how attitudes toward exploration investment are affected by government policy while the latter rates regions based on of their geologic attractiveness.
The second-most attractive region was found to be Arizona, another state in the United States, which climbed up from its 2019 ninth place ranking. The Saskatchewan province in Canada also moved up eight spots from its 2019 ranking to third place in 2020. This makes Saskatchewan province the most attractive region for mining investment in Canada.
On the other hand, Western Australia dropped from the first place as the most attractive region in 2019, to fourth place in 2020. Alaska also descended one spot, from fourth place in 2019 to fifth place last year. The remaining five regions, which make up the top-ten most attractive regions for mining investors are Quebec, Labrador and Newfoundland, South Australia, Finland and Idaho.
With regard to ranks on the Investment Attractiveness Index, after Australia, Canada is the second most attractive jurisdiction for investment. This year, the Canadian provinces of Labrador and Newfoundland, Quebec and Saskatchewan all made it to the top-10 most attractive regions, displacing Sweden, Ireland and Portugal, which is a significant climb. In 2019, no jurisdiction from Canada was featured in the list of the 10 most attractive regions.
One of the authors of the Fraser Institute report, Elmira Aliakbari, stated that Canada’s general improvement on investment attractiveness was mainly driven by better comprehension of the country’s mineral potential by investors, which make up roughly 60% on the main index. Aliakbari also declared that policymakers in every territory and province should note that mineral deposits aren’t enough to attract more investments.
Additionally, answers given by the mining executives who participated in the survey found that the 10 least attractive regions for investment are Chubut province in Argentina, Tanzania, Indonesia, La Rioja (which is also in Argentina), Bolivia, Mendoza (located in Argentina), Zimbabwe, Spain and Michigan.
Speaking of ideal mining destinations, Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) has a pipeline of precious metals projects in Germany, Idaho and Mexico, which all indicate sustained growth for the company.
NOTE TO INVESTORS: The latest news and updates relating to Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) are available in the company’s newsroom at https://ibn.fm/EXN
About MiningNewsWire
MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.
To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)
For more information, please visit https://www.MiningNewsWire.com
Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer
MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com
MiningNewsWire is part of the InvestorBrandNetwork.
Shares of Energy Fuels Inc (NYSE American:UUUU) traded at a new 52-week high today of $6.95. So far today approximately 7.6 million shares have been exchanged, as compared to an average 30-day volume of 5.3 million shares.
Energy Fuels is the largest uranium producer in the U.S. and holds more production capacity and uranium resources than any other U.S. producer. The Company also produces vanadium. Headquartered in Colorado, Energy Fuels holds three of America�s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch ISR Facility in Wyoming, and the Alta Mesa ISR Facility in Texas. The producing White Mesa Mill is the only conventional uranium mill in the U.S. and has a licensed capacity of 8 million pounds of U3O8 per year. Nichols Ranch is in production and has a licensed capacity of 2 million pounds of U3O8 per year. Alta Mesa is currently on standby.
Energy Fuels Inc share prices have moved between a 52-week high of $6.95 and a 52-week low of $0.78 and are now trading 718% above that low price at $6.38 per share.
Potential upside of 0.9% exists for Energy Fuels Inc, based on a current level of $6.38 and analysts’ average consensus price target of $6.44.
Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer
Cybin (NEO: CYBN) (OTC: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today announced its successful uplisting from the OTC Pink Sheets to the OTCQB(R) Venture Market. Cybin will commence trading on the OTCQB under the symbol “CLXPF” at market open on March 8, 2021. “Listing on the OTCQB is another important milestone for Cybin. It affords us greater visibility within the investment community, which should enhance our liquidity and increase our access to institutional and retail investors,” said Doug Drysdale, CEO of Cybin. “This additional capital markets exposure will be valuable as we continue to support our psychedelic drug development programs to potentially treat mental health disorders, such as major depressive disorder and other therapy-resistant psychiatric disorders.”
To view the full press release, visit http://ibn.fm/HrMBJ
About Cybin Inc.
Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. For more information, visit the company’s website at www.Cybin.com.
NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at http://ibn.fm/CYBN
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
The coronavirus pandemic has affected many industries and economies worldwide, in addition to causing the deaths of more than 500,000 people in America and 2.3-plus million people globally. Understanding how seasonal temperature changes affect virus transmission is crucial in decreasing the spread of the virus in the future.
The virus that causes the coronavirus, SARS-CoV-2, is part of a larger coronavirus family, which aren’t spread as easily in warmer parts and during humid times in the year. Instead, the spread of these viruses increases in less humid times in cooler places.
With this information in mind, researchers from the Joint Artificial Intelligence Center, Christina Lee Brown Envirome Institute, University of Louisville, the Johns Hopkins University School of Medicine and other institutions hypothesize that atmospheric temperatures would also impact SARS-CoV-2 transmission.
To prove this, the scientists compared the number of coronavirus cases that were logged last year in 50 nations in the northern hemisphere between January 22 and April 6 to daily data of low temperatures. Their findings, which were reported in “PLOS ONE,” demonstrate that as the temperatures increased, the rate of new coronavirus cases declined.
Their analysis of collected data shows that between 30–100º F, a one-degree rise in everyday low temperature was linked to a 1% drop in the rate of coronavirus cases. On the other hand, a one-degree drop in temperature was linked to a 3.7% surge in coronavirus cases. It should be noted that because the researchers began examining the data in the pandemic’s early days, these findings weren’t influenced significantly by any social efforts or restrictions that were imposed later in an attempt to contain the virus.
The director of the Brown Envirome Institute and co-author of the study, Aruni Bhatnagar, stated that the research showed that the coronavirus had a seasonal component, adding that the impact temperature had on its transmission rate was also modified by factors such as time spent indoors and social distancing. He asserted that it was various factors combined that ultimately led to the spread of the coronavirus, not one primary factor.
The researchers noted that while the U.S. recorded surges in coronavirus cases over the summer, cooler summer temperatures may have led to even more cases. The scientists came to the conclusion that summer months would be linked to slowed rates of coronavirus transmission, much like other seasonal respiratory viruses. They noted that this seasonal effect could come in handy in helping time the virus’ reoccurrence and in planning for social gatherings.
Still on the subject of COVID-19, XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) has a COVID-19 rapid diagnostic product that will soon be gaining European commercial approval.
NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://ibn.fm/XPHYF
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
Uranium Energy (NYSE American: UEC), a Corpus Christi, Texas-based uranium mining and exploration company, today announced that Spencer Abraham, UEC’s chairman and former United States Secretary of Energy, will be speaking tomorrow, March 3, 2021, in a virtual fireside chat at the BMO Global Metals and Mining Conference. Interested parties can access Abraham’s live fireside chat at 5:45 p.m. ET through the registration link at https://ibn.fm/tXw7o. In addition, a replay of the session will be made available on the BMO conference web app after the event and will be accessible to registered attendees.
To view the full press release, visit https://ibn.fm/LS18P
About Uranium Energy Corp.
Uranium Energy is a U.S.-based uranium mining and exploration company. In South Texas, the company’s hub-and-spoke operations are anchored by the fully licensed Hobson Processing Facility, which is central to the Palangana, Burke Hollow and Goliad ISR projects. In Wyoming, UEC controls the Reno Creek project, which is the largest permitted, pre-construction ISR uranium project in the U.S. Additionally, the company controls a pipeline of uranium projects in Arizona, New Mexico and Paraguay, a uranium/vanadium project in Colorado and a large, high-grade ferro-titanium project in Paraguay. The company’s operations are managed by professionals with a recognized profile for excellence in their industry, a profile based on many decades of hands-on experience in the key facets of uranium exploration, development and mining. For more information about the company, visit www.UraniumEnergy.com.
NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at http://ibn.fm/UEC
About MiningNewsWire
MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.
To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)
For more information, please visit https://www.MiningNewsWire.com
Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer
MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com
MiningNewsWire is part of the InvestorBrandNetwork.
- High Pressure Processing (“HPP”) has become a highly successful method to reduce pathogens and extend shelf-life in food and beverages while maintaining taste, nutrition, flavor, and texture
- The HPP food and beverage market was estimated at $15.5 billion in 2019
- PBI’s UST process combines benefits of HPP with high shear and controlled temperature to achieve effective anti-microbial effects and long-term preservation with reduced or no chemicals
- Academia-Industry partnership will give global food companies in Consortium an early look and first-hand use of UST, with a right to non-exclusively license UST for their own commercial use
- This revolutionary, transformative technology is not just applicable to the massive food and beverage markets, but to the pharmaceutical, nutraceutical, cosmetics, and agriculture markets
- The Consortium resulted from research initially sponsored by the USDA NIFA
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative, pressure-based solutions for the worldwide life sciences and other industries, and the College of Food, Agricultural, and Environmental Sciences (“CFAES”) at The Ohio State University (“Ohio State”) announced a wide-ranging agreement for the implementation of PBI’s patented Ultra Shear Technology(TM) (“UST”) platform. PBI is developing three different models of the UST processing instrument, named the BaroShear: a small footprint benchtop model, a medium capacity floor model, and an industrial scale, continuous flow model for high capacity. All three models are designed to perform high shear processing of liquids under controlled temperatures and pressure conditions. They will be set up for demonstration and hands-on use in the world-renowned Ohio State food pilot plant (https://ibn.fm/BxEdd).
PBI is a leader in development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food/beverage industries. Together with Ohio State, whose CFAES is a globally recognized leader in the food sciences, PBI has formed a food industry consortium to advance the commercialization of its UST platform through the quality enhancement of beverages, condiments, sauces, and other liquid foods. Consortium members will have access to the UST technology in the Ohio State pilot plant and first rights to license all new UST applications developed through the Consortium.
The primary goals of the Consortium are:
- Develop and improve new commercial applications of UST
- Help address potential regulatory issues through scientific support
- Allow global food companies worldwide to experience UST product development and pre-commercialization efforts first-hand
Additionally, Consortium members will be rewarded with “first-look” opportunities to all new UST developments and first rights to non-exclusively license all new applications for commercial purposes.
According to Pressure BioSciences President and CEO Richard T. Schumacher, the Consortium will welcome a global group of preeminent leading food and beverage companies as members. “Each will contribute annually towards the Consortium’s operations, with funds supporting R&D at both PBI and Ohio State while participating as an advisory council to nominate, prioritize and direct UST applications development amongst the myriad opportunities that invite our attention,” he explained.
Food companies worldwide will have access to the Consortium, and members will help direct the scientific effort of OSU and PBI across prospective liquid food and beverage projects. The current topics of interest include:
- Spore inactivation and control of other pathogen and spoilage factors
- Enhancement of taste, smell, and other sensory qualities in liquid foods
- Formation of highly stable products that are suitable for ambient temperature storage, transportation, and distribution
Over the last two decades, high pressure processing (“HPP”) has established itself as a very successful clean-label (reduced or no chemical additives) approach for food safety and improved product life, according to PBI Senior Vice President of Engineering Dr. Edmund Y. Ting. As a result, the high pressure processing (“HPP”) food market reached $15.5 billion in 2019 and is expected to increase substantially through 2025 (https://ibn.fm/sY5RY). The HPP market makes some (not all) food safer, more stable, more nutritious, better tasting, and with fewer chemicals (clean label).
According to Dr. Edmund Ting, Sr. VP of Engineering at PBI and a pioneer in the development of HPP, “HPP has proven to be very effective in reducing food-borne pathogens and extending shelf-life in pre-packaged foods (e.g., juices and ready-to-eat meats), thus eliminating the need for chemical additives. However, because it is only a pasteurization process, and does not render food “commercially sterile”, HPP-processed food must be shipped, stored, and maintained under refrigeration throughout the entire chain of distribution and retail sale. We believe that Ultra Shear Technology will provide economical solutions to these problems, and will offer an additional, clean label processing choice to both consumers and the food industry around the world.”
The potential of UST is not just limited to food and beverages. Through this revolutionary platform, vitamins and cannabinoids could be infused into beverages, remaining in them without precipitating out, as is often seen today. Gels, creams, ointments, and other lotions could penetrate the skin faster and more completely, bringing the active ingredient to where it needs to be faster and with higher bioavailability. Vaccines and therapeutics could be enhanced and improved. The applications and benefits are seemingly endless.
PBI and Ohio State gratefully acknowledge the initial research support by the USDA NIFA, which resulted in the Consortium.
For more information, visit the company’s website at www.PressureBioSciences.com.
NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), a multifaceted marketplace providing consumers all things plant based, has released its interim unaudited financial results for the three and nine months ended December 31, 2020. A highlight of the report is the company’s record revenue of C$1,832,484 for the three months ended December 31, 2020 — an increase of 298% over gross revenue of C$459,982 reported in Q2. The report also noted that PlantX saw a gross margin of 20% for the same period, an increase from 5.7% in Q2. In addition, cost of sales for the company over the same period totaled C$1,465,879. The announcement noted that the record increase in revenue and sales positions was attributed primarily to the company’s expanded product offerings, innovative partnerships and strategic acquisitions; the report positions PlantX as one of the highest-growing leaders in the plant-based industry. “Over the last three quarters we have seen increases in revenue, which emphasizes the impact and potential that PlantX has in the plant-based marketplace,” said PlantX founder Sean Dollinger in the press release. “We seek to build on our current financial results, and deliver some of the most high-quality and dynamic experiences and products to our plant-based community through our evolving growth strategy and commitment to excellence.”
To view the full press release, visit: https://ibn.fm/vABxw
About PlantX Life Inc.
As the digital face of the plant-based community, PlantX’s platform is the one-stop-shop for everything plant-based. With its fast growing category verticals, the company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the company currently has plans underway to expand its product lines to include cosmetics, clothing, and its own water brand — but the business is not limited to an e-commerce platform. The company uses its digital platform to build a community of like-minded consumers, and most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs and brands. The company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle, and thriving in a longer, healthier and happier life. For more information about this company, please visit www.PlantX.com and www.PlantX.ca.
NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at http://ibn.fm/PLTXF
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
Mohawk Group (NASDAQ: MWK), a technology-enabled consumer products company, has scheduled a conference call to report fourth-quarter and year-end financial results. The call is scheduled for Monday, March 8, 2021, at 5 p.m. ET. Investors and other interested parties are invited to participate in the call, which will be accessible by telephone and via the internet. Participants from within the United States can dial (877) 295-1077, and participants from outside the United States should dial (470) 495-9485; the conference ID is 4271887. As an alternative, participants can also watch the broadcast live. In addition, an archived replay of the call will be available in the investors section of the Mohawk corporate website for a short time after the call is concluded.
To view the full press release, visit https://ibn.fm/ht4vW
About Mohawk Group Holdings, Inc.
Mohawk Group is a rapidly growing technology-enabled consumer products company that uses machine learning, natural language processing, and data analytics to design, develop, market and sell products. Mohawk predominantly operates through online retail channels such as Amazon and Walmart. Mohawk has twelve owned and operated brands and sells products in multiple categories, including home and kitchen appliances, kitchenware, environmental appliances (i.e., dehumidifiers and air conditioners), beauty-related products and, to a lesser extent, consumer electronics. Mohawk was founded on the premise that if a company selling consumer packaged goods was founded today, it would apply artificial intelligence and machine learning, the synthesis of massive quantities of data and the use of social proof to validate high caliber product offerings as opposed to over-reliance on brand value and other traditional marketing tactics. For more information about this company, please visit www.MohawkGP.com.
NOTE TO INVESTORS: The latest news and updates relating to MWK are available in the company’s newsroom at http://ibn.fm/MWK
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
- Ideanomics’ Mobility and Capital divisions provide shareholders with access to disruptive and high-growth opportunities
- The company’s primary shareholders include two billionaire families – former chairman Dr. Bruno Wu and Vice Chairman Mr. Shane McMahon
- The company has raised approximately $400 million in six months to fund new investments and acquisitions in revenue-based growth focused on EV and fintech companies
- Ideanomics Mobility consists of five companies and generates revenue from the entire EV ecosystem from vehicle and battery sales to financing, leasing and insurance, all the way through charging and energy services
- The EV market is expected to grow exponentially, driven by growing public acceptance and the current U.S. administration’s support as it works toward a 100% clean-energy economy
- Ideanomics Capital is focused on financial technologies and their disruptive potential across financial services, ranging from markets and digital assets to real estate
Ideanomics (NASDAQ: IDEX) is a global company facilitating the adoption of commercial electric vehicles and supporting next-generation financial services and fintech products. Ideanomics is currently divided into two divisions – mobility and capital. These divisions provide shareholders with access to disruptive and high-growth opportunities.
The company expects 2021 to be another growth year after it raised approximately $400 million over the past six months. This funding has already been put to good use with acquisitions of Wireless Advanced Vehicle Electrification (“WAVE”) and Timios. With roughly $200 million still on the balance sheet, Ideanomics continues to look for new investments and acquisitions in revenue-based opportunities focused on EV and fintech businesses.
Founded in 2004, Ideanomics is headquartered in New York, New York, with additional offices in Hangzhou, Beijing and Qingdao, China. Its current operations span the United States, China, Ukraine and Malaysia.
Ideanomics Mobility
Ideanomics Mobility is focused on the EV market. The global commercial EV market was valued at $34.7 billion in 2018 and is expected to grow at a CAGR of 39.9% through 2022 to reach a total of $132.73 billion (https://ibn.fm/pPrf4). According to a survey by Grand View Research, the global EV charging infrastructure market is also expected to grow and reach $144.97 billion in 2028, expanding at a CAGR of 33.4% from 2021 to 2028.
This growth is expected to be driven by increased support of electric vehicles from the public, as well as the current U.S. administration, which has a goal of achieving a 100% clean-energy economy.
The Ideanomics Mobility unit consists of five companies:
- Mobile Energy Global (“MEG”) – Wholly owned China-based service provider of the Sales-to-Finance-to-Charging (“S2F2C”) business model to assist commercial fleet operators on EV enablement. Recent sales include 2,000 units of D1, BYD’s custom electric ride-hailing vehicle.
- Medici Motor Works – Wholly owned North America division. MMW will develop zero-emissions specialty vehicles, trucks, buses and vans for the North American market.
- Wireless Advanced Vehicle Electrification (“WAVE”) – Wholly owned Utah-based commercial EV charging technology company with a specialized offering of in-ground wireless charging for commercial vehicles. WAVE’s chargers power the Antelope Valley Transportation Authority, the largest municipal EV bus system in the country. Its revenue for 2020 exceeded $7 million, and it boasts a robust pipeline for 2021 and beyond.
- Treeletrik – Majority investment in Malaysian-based OEM will service a high-demand market – electric delivery mopeds. Treeletrik has obtained certifications in Thailand and Indonesia, with orders secured for 2021. Its North American marketing program is expected to commence in 2021. As a part of the ESG initiative, one tree will be planted for every unit sold.
- Solectrac – Minority investment in California-based electric tractor company. Solectrac manufactures 100% electric tractors to benefit farmers, crops and the planet at a time when the agriculture market remains virtually unaddressed by EV solutions.
- Silk EV – Minority investment in hyper car and performance car design company, which provides access to the high-end battery and charging technology development ecosystem.
Ideanomics is generating EV revenue from its Sales to Financing to Charging (“S2F2C”) business model, which features three operating areas:
- Vehicle and Battery Sales: Medici, Treeletrik and Solectrac cover three key market segments
- Financing, Leasing and Insurance: Offering financial services to fleet customers, commission delivery and origination fee-based revenue
- Charging and Energy Services: Offering charging as a service, battery swap programs and WAVE wireless charging products
Ideanomics Capital
Ideanomics Capital is focused on providing disruptive fintech solutions across the entire board of financial services, ranging from financial markets to digital securities and assets to mortgages and more. More mainstream institutions and a growing number of companies have increased their digital securities services, along with institutional investments boosting bitcoin and the emergence of favorable regulatory developments, creating ample opportunities for widespread adoption of financial technologies.
Additionally, the U.S. real estate industry is ripe for technologization, as it currently is fragmented, antiquated, opaque and largely untouched by tech innovation. However, the expanding market, with U.S. home sales expected to grow 21.9% in 2021, and the increased digitization of all business spaces are expected to promote a digital-first experience as the new industry standard this year and beyond (https://ibn.fm/DwsUv).
The Ideanomics Capital unit consists of five companies:
- Timios – Wholly owned subsidiary bringing real estate into the 21st century by providing value-add, fee-based services addressing the title and closing process of home buying and mortgage transactions. Timios works to create transparency and efficiency within the market. Timios ended 2020 as a cash flow and EBITDA positive business.
- The Delaware Board of Trade (“DBOT”) – Wholly owned FINRA-regulated ATS and broker dealer based in Delaware.
- Liquefy – Minority investment bringing innovation to investment in real assets with blockchain technology by increasing efficiency in fractional ownership, lowering entry to investment barriers and unlocking liquidity in assets that were previously illiquid.
- Technology Metals Market (“TM2”) – Minority investment in UK company delivering a direct investment and trading market for technology metals with a newly accessible technology metals asset class for inventory diversification. The traded metals are 100% backed by physical metals.
- Intelligenta – Investment providing AI and machine learning solutions for financial institutions and regulators.
Management Team
Alf Poor is Ideanomics’ Chief Executive Officer. He is a client-focused and profit-driven executive who has a track record of success in rapidly growing technology companies and large, multi-national organizations. Mr. Poor’s expertise includes business planning, financing and creating and implementing corporate governance policies, as well as handling management across organizations. His specialization is working with cross-border and multi-national startups. Before taking the CEO role at Ideanomics, he was the CEO for Global Data Sentinel.
Conor McCarthy is the company’s Chief Financial Officer. He is a strategic and operationally oriented management-level professional. His extensive international experience is within the fintech, data science and advertising technology sectors. Mr. McCarthy has experience with public companies, PE, and VC-backed firms. His specializations are financial and management reporting, planning and analysis, financial modelling, performance metrics, KPIs, venture borrowing, Series A equity funding, ERP system implementation, international business operations, and acquisition due diligence and integration. Before joining Ideanomics, Mr. McCarthy most recently held a CFO position at OS33. Prior to that, he was CFO for Intent Media Inc.
Kate Lam is the company’s Managing Director of Financial Products. She is highly regarded for her fixed income capital marketing skills across Asia and the United States. Ms. Lam has over 25 years of experience in the financial markets industry, dealing with many asset classes and clients. Having spent a few years in the fintech startup industry, her skills bridge the gap between traditional financial assets and new technological innovations. She has held senior management positions at Bear Sterns, Deutsche Bank and Standard Chartered Bank.
Keith Byers is Ideanomics’ Senior Vice President of Operations. He has extensive experience managing strategic relationships with key clients and deepening the relationships through innovation and successful engagement strategies. Before Ideanomics, Mr. Byers was the Managing Partner and Head of Operations for Gain Theory. He has a Master of Arts – MA, Economics from Heriot-Watt University and a Master of Science – Economics from The University of Edinburgh.
Tony Sklar is the company’s Senior Vice President of Investor Relations. He is a communication strategist and has worked for multi-faceted companies with global operations. Mr. Sklar handles omni-channel distribution using intelligence platforms and data insights for strategic planning, international expansion and marketing channels. His specialties include project management with digital strategy and transformation, ICO, marketing, blockchain and strategic partnerships. In addition to his role with Ideanomics, he is also a board member for the Delaware Board of Trade and the host and senior technology reporter for Far From TV.
For more information, visit the company’s website at www.Ideanomics.com.
NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
Cannabidiol Market Anticipated To Grow At A Lucrative Rate Through 2027 As Consumer Demand Rapidly Increases
Palm Beach, FL – March 2, 2021 – Due to its healing properties, the demand for cannabidiol (CBD) for health and wellness purposes is high, which is the major factor driving the market growth. In addition, the rising acceptance and use of products due to government approvals is a major factor expected to boost production for CBD-infused products. Cannabidiol derived from hemp is anticipated to witness rapid growth owing to increasing demand from the pharmaceutical sector and rising awareness among consumers regarding health. Increasing consumer disposable income along with the legalization of medicinal cannabis is anticipated to have a positive impact on the demand for cannabidiol in the pharmaceutical sector. Oils, tinctures, concentrate, capsules, topical solutions such as slaves, lip balms, lotions, and edibles such as baked goods, coffee, chocolates, gums, and candies are some of the CBD products which are in high demand. According to reports from Grand View Research the global cannabidiol; market size is expected to reach USD 13.4 billion by 2028, and is expected to expand at a CAGR of 21.2% from 2021 to 2028. The report said: “Increasing awareness about the health benefits of cannabidiol (CBD), changing consumer opinion, and attitude toward CBD products are some of the key factors driving the demand for these products. Furthermore, increasing demand for cannabidiol from various end-user industries such as food and beverage, personal care and cosmetics, and pharmaceuticals is expected to trigger market growth…” Active Companies active today in the cannabis related markets include: Discover Wellness Solutions Inc. (CSE: WLNS), HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF), Canopy Growth Corporation , (TSX: WEED) (NASDAQ: CGC), Aphria Inc. (TSX: APHA) (NASDAQ: APHA), Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF).
The Grand View Research report continued with: “In 2020, the hemp segment accounted for the largest revenue share valued at USD 1.7 billion, owing to the rising awareness regarding the health benefits of products infused with cannabidiol derived from marijuana. On the other hand, hemp-derived CBD is expected to witness the fastest CAGR over the forecast period, owing to the increasing legalization of hemp in various countries. Increasing awareness of cannabidiol’s therapeutic benefits has influenced a buyer to buy cannabidiol products, regardless of their cost. As these have a greater profit margin, commercial retailers are now focusing on selling cannabis-based products. Numerous health and wellness retailers are offering CBD-based products, such as Rite Aid, CVS Health, and Walgreens Boots Alliance. In addition, CVS Health decides to offer CBD topicals all over its 800 stores and Walgreens Boots Alliance is selling CBD-containing topicals across 1500 of its stores in the U.S.”
Discover Wellness Solutions Inc. (CSE: WLNS.CNQ) BREAKING NEWS: Discover Wellness Solutions Signs MOU and Quad Play to Enter Thailand’s Deregulating Hemp Extract Market – Discover Wellness Solutions Inc. (formerly RMMI Corp.) (“Discover Wellness”, “DWS” or the “Company”), a licensed producer and processor under the Cannabis Act (Canada), is pleased to announce that it has entered into a Memorandum of Understanding on Co-operation on Arrangement of Hemp Business in Thailand with Quad Play (“ QP ”) of Thailand (the “ MOU ”). Thailand is an attractive market for Discover Wellness as it is the first country globally to deregulate hemp-derived oils and extracts which allows it to be included in consumer product goods. The MOU is the first step in DWS and QP creating a joint business for the development and marketing of consumer-packaged goods infused with hemp extracts for the Asian market, including wellness, food, beverage and cosmetics products.
Under the terms of the MOU QP would import high-potency hemp seeds from DWS for distribution and cultivation in Thailand. QP will become an exclusive supplier of DWS seeds in Thailand. The agreement is subject to an initial trial order of 20,000 seeds. Upon successful completion of the trial order, QP will pre-purchase 200,000 seeds (US$200,000 value) and in return DWS will receive a 4% equity interest in QP. Additionally, DWS has a Right of First Refusal (“ ROFR ”) to acquire control of QP once regulations in Thailand allows for control by foreign companies.
QP will arrange for cooperation with producers in Thailand of medicine, food and drinks products who wish to incorporate hemp oils and extracts in their products. By this arrangement, DWS can use Thailand as a base for distributing seeds, cultivating and producing DWS’s products for sales in Thailand domestically and internationally.
Effective, January 29, 2021, the Thai government amended its hemp regulations. Under its new definition hemp with <1% THC can now be imported, exported and used for government, industrial, medical and research purposes.
“We view this arrangement as a first step for Discover Wellness’ global distribution strategy into the fast-growing food and beverage markets of Asia, a potential $5.8 billion market by 2024 according to Prohibition Partners. We are excited to be working with QP as our exclusive partner and leverage their deep relationships with traditional consumer packaged goods companies within Thailand and the broader Asian market.” commented Peter Cheung, Interim Chief Executive Officer and Chief Financial Officer. Read the full Press Release that includes more Financial Results details for INLB at: https://www.financialnewsmedia.com/news-wlns
In other active company news in the markets this week:
HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, recently announced that Mount Sinai Medical Hospital, New York City, has selected HempFusion CBD to be used as the exclusive brand and the sole supplier in a six-month clinical trial.
The clinical trial, comprised of two studies, is being conducted by Dr. David Harnick, a board-certified cardiologist and electrophysiologist and Assistant Professor in Medicine and Cardiology at Mount Sinai, and is one of the first of its kind in the area of CBD’s effect on targeted cardiology markers. Dr. Harnick has constructed this long-term clinical trial to collect data that will assist in a deeper understanding of CBD’s effect on the body. He has chosen HempFusion for its rigors in regulatory standards, toxicology studies for safety and quality control adherence. The randomized, double-blinded, placebo-controlled
Canopy Growth Corporation , (TSX: WEED) (NASDAQ: CGC) recently announce d its financial results for the third quarter fiscal 2021 ended December 31, 2020. All financial information in this press release is reported in millions of Canadian dollars, unless otherwise indicated.
“We delivered another quarter of record net revenue, with growth across all our businesses, led by improved commercial and supply chain execution,” said David Klein, CEO. “We are building a track record of winning in our core markets, while also accelerating our U.S. growth strategy with the momentum building behind the promising cannabis reform in the U.S.”
“We are executing against our cost savings program, with several initiatives already completed and more underway to build a leaner and more agile business,” added Mike Lee, CFO. “These cost savings, along with our top-line growth and continued cost discipline, puts Canopy firmly on a path to achieve profitability during Fiscal 2022, with further improvement anticipated beyond.”
Aphria Inc. (TSX: APHA) (NASDAQ: APHA), a leading global cannabis-lifestyle consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, and Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, recently announced the launch of the new website: www.aphriatilraytogether.com.
This new, dedicated resource seeks to provide shareholders of both companies with pertinent information, news and updates leading up to the special meetings of shareholders at which Aphria’s and Tilray’s respective shareholders will vote on the resolutions necessary to implement the proposed business combination of the two companies (the “Transaction” ). The website will also allow shareholders and other interested parties to register for Transaction updates that are made publicly available, so they receive information directly to their e-mail addresses.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) a leading U.S. provider of consumer products in cannabis, recently announced that it would expand its line of Select brand products into Utah, starting with the brand’s popular Select Elite cartridges.
Select, America’s #1 Cannabis Oil Brand, was acquired by Curaleaf in February 2020, and is currently available across 17 states including Arizona, California, Colorado, Connecticut, Florida, Illinois, Maine, Massachusetts, Michigan, Maryland, New York, Nevada, Ohio, Oklahoma, Oregon, Pennsylvania, and Utah.
Select Elite will be accessible to patients at medical cannabis pharmacies across the state in the coming weeks, starting with immediate availability at the Curaleaf pharmacy in Lehi, UT. As one of the fourteen licensed retailers to operate within Utah’s medical market, Curaleaf Lehi has proudly served thousands of Utah’s 18,400+ active patient cardholders and looks forward to providing more accessibility to high-quality medical cannabis products, innovative consumption formats, and leading national brands to the state’s growing patient base.
DISCLAIMER: FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third- party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM was compensated forty six hundred dollars for news coverage of current press release issued by Item Discover Wellness Solutions Inc. by a non-affiliated third party. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.
Energy Fuels (NYSE American: UUUU) (TSX: EFR) has partnered with Neo Performance Materials (TSX: NEO) to unveil a new rare earth production initiative spanning both North American and European critical material supply chains. The separated rare earth products produced in Europe from U.S.-sourced feedstock should strengthen and diversify the U.S. and European rare earth supply chains. As outlined in the announcement, the initiative will produce value-added rare earth products from natural monazite sands processed by Energy Fuels in the Southeastern United States. The resulting mixed rare earth carbonate will be shipped to Neo’s rare earth separations facility in Estonia, where it will be processed into separated rare earth materials for use in rare earth permanent magnets and other rare earth-based advanced materials. In addition to the initiative with Neo, Energy Fuels continues to assess other opportunities for developing value-added U.S rare earth production capabilities in the future. “Together, Energy Fuels, Neo and Chemours have successfully created an integrated rare earth supply chain based in the U.S. and Europe,” stated Energy Fuels president and CEO Mark S. Chalmers in the press release. “Monazite is coveted globally as one of the highest-value rare earth minerals in the world, due to its excellent distribution of neodymium and praseodymium (‘NdPr’), as well as ‘heavy’ rare earths. It is already mined here in the U.S. and elsewhere around the world. However, until now, there has been no integrated ability to process monazite in the U.S. or Europe into the rare earth materials needed to supply the rapidly increasing demand for electric vehicles, renewable energy systems, and other clean energy and advanced technologies. Energy Fuels is proud to help solve this challenge for both U.S. and European markets. Under the agreement announced today, we plan to supply all or a portion of our mixed rare earth carbonate to Neo for several years, while also developing our own separation, metals, alloys, and other downstream rare earth capabilities at the White Mesa Mill for supply into the U.S. as domestic markets grow.”
To view the full press release, visit https://ibn.fm/PEjwb
About Energy Fuels Inc.
Energy Fuels is a leading U.S.-based uranium mining company, supplying U3O8 (“U308”) to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant, and expects to commence commercial production of rare earth element (“REE”) carbonate in 2021. Its corporate offices are in Lakewood, Colorado, near Denver, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming, and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the United States today, has a licensed capacity of over 8 million pounds of U3O8 per year, has the ability to produce vanadium when market conditions warrant, and is completing final test-work for the production of REE carbonate from various uranium-bearing ores. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also on standby and has a licensed capacity of 1.5 million pounds of U3O8 per year. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S. along with several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. For more information, visit the company’s website at www.EnergyFuels.com.
NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU
About MiningNewsWire
MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.
To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)
For more information, please visit https://www.MiningNewsWire.com
Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer
MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com
MiningNewsWire is part of the InvestorBrandNetwork.
Last week, the first psychedelic therapy clinic in the province launched in Calgary. The clinic is located in northwest Calgary and will be used as a mental health professional training center. Dr. Ravinder Bains, who is the facility’s chief medical officer, will be overseeing the psychedelic therapy.
In an interview, David Harder, CEO of the ATMA Urban Journey Clinic, stated that the clinic was the result of years of a lot of studies and research. He noted that psychedelics did not work in the same way that standard psychotic medications or antidepressants worked.
Harder explained that while conventional medications prescribed for conditions such as PTSD, anxiety or depression often made a person numb or made them suppress their emotions, psychedelics brought these emotions to the surface, which made it easier for therapists to work with affected individuals and help them deal with the issues that affected them.
Tony White, a cancer sufferer in January became the first individual to receive federally approved psilocybin mushroom treatment in Alberta, disclosed that the psychedelic treatment had helped him release some of the depression and anxiety he’d been plagued with since he was diagnosed with terminal cancer. Later in mid-January, White revealed that he’d felt at peace immediately after the treatment had been administered as well as afterwards.
From the ongoing clinical trials, psilocybin, which is the active psychedelic component in magic mushrooms, has shown a lot of potential in helping alleviate end-of-life distress for cancer patients. Since August 2020, Health Canada has approved 20 exemptions to cancer patients to treat their end-of-life distress.
At the moment, Health Canada only grants exemptions that permit one-on-one psilocybin therapy sessions for patients who are terminally ill. The new clinic will continue its operations with this mandate in place, although Harder hopes that the options will increase with time.
Harder revealed that they were also applying on behalf of some individuals suffering from mental health conditions such as PTSD, anxiety and depression, adding that he hoped that Health Canada would approve these applications.
He also observed that while the clinic would offer palliative care therapy at no cost, only psilocybin therapy would be administered in the clinic for now. He explained that this was because it was challenging to find psychedelics in a pure state as they’re often laced with cutting agents and fentanyl.
Still in Canada, Cybin Inc. (NEO: CYBN) (OTC: CLXPF) has eight provisional patents, all connected to psychedelic medicines. For example, one is for technology to nebulize psychedelic remedies while another is for oral film technology to eliminate the need for people to swallow pills.
NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (OTC: CLXPF) are available in the company’s newsroom at https://ibn.fm/CYBN
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
- Berubicin is CNS Pharmaceuticals’ lead product candidate for treatment of Glioblastoma Multiforme, and has the potential to be the first anthracycline to cross the blood-brain barrier based on limited results from a Phase 1 trial
- The market for GBM treatment is estimated to reach $3.3 billion in 2024, growing at a CAGR of 17.4%
- CNS, in collaboration with sublicensee partner WPD Pharmaceuticals, is currently planning three Berubicin clinical trials, all to start within the year – two Phase II adult trials and a pediatric Phase I trial
Glioblastoma Multiforme (“GBM”) is one of the most aggressive forms of brain cancer in the adult population and is currently considered incurable, with a significant recurrence rate in most patients. Even with gross total resection of the GBM tumor, there is always a microscopic amount of disease that gets left behind. A gross total resection of GBM is defined as removing at least 98% or more of the tumor that has been contrast-enhanced and visible on an MRI.
CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biotechnology company that is currently specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, hopes to address this issue and improve the lives of GBM patients while also lowering recurrence risks with its lead drug candidate, Berubicin.
Developed by Dr. Waldemar Priebe, Ph.D., the Chairman of the Scientific Advisory Board for CNS Pharmaceuticals, and a Professor of Medicinal Chemistry at the University of Texas MD Anderson Cancer Center, Berubicin appears (based on limited Phase 1 trial results) to be the first anthracycline to cross the blood-brain barrier (“BBB”) in adults, reaching the tumor’s cancerous cells. Anthracyclines are among some of the most effective drugs ever created for cancer treatment. They have various uses within cancer treatments, including breast, stomach, uterine, ovarian, bladder, lung, and hematological malignancies. To date, there has not been any evidence that anthracyclines can cross the BBB.
In December 2020, the U.S. Food and Drug Administration (“FDA”) cleared CNS Pharmaceuticals’ investigational new drug (“IND”) application. This approval enables the company to begin a human trial and ship Berubicin across state lines to clinical investigators.
CNS Pharmaceuticals is optimistic about the three upcoming clinical trials that are scheduled for Berubicin, and is enthusiastic about the first pediatric study that will begin later this year in Poland under the oversight of sublicensee partner WPD Pharmaceuticals. WPD will also be running a concurrent adult Phase II trial in Poland, while CNS Pharmaceuticals will organize a separate randomized, controlled Phase II adult trial beginning in the United States but slated to expand into western Europe.
Commenting on the plans for the Berubicin development program during a podcast interview with Sid Vaidaya and Eric Gershey, CNS Pharmaceuticals CEO John Climaco said, “This is the biggest news we’ve announced since our IPO back in November 2019. Based on that IND approval, we expect, in the next 90 to 120 days, we will go from zero active clinical trials today to three active clinical trials” (https://ibn.fm/4azlQ).
The market for GBM treatment has grown exponentially over the last few years, being expected to reach $3.3 billion by 2024, from $659 million in 2014 (https://ibn.fm/XOkXw). There are multiple companies making progress in this market as a result of increased focus and investment into research and development of GBM therapeutics. With Berubicin’s apparent ability to breach the BBB and the planned Phase I and Phase II trials, CNS Pharmaceuticals is uniquely positioned to capitalize on this market growth and secure a leading role in the sector.
For more information, visit the company’s website at www.CNSPharma.com
NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases, today announced that its chairman and CEO, James Sapirstein, will participate in a “fireside chat” with Yi Chen, managing director, Equity Research at H.C. Wainwright, during the H.C. Wainwright Global Life Sciences Conference being held virtually March 9-11, 2021. Sapirstein will provide an overview of AzurRx’ business and clinical development programs and discuss anticipated 2021 milestones during the fireside chat scheduled to take place at 7:00 a.m. ET on Tuesday, March 9. Additionally, Sapirstein and members of the AzurRx management team will be participating in virtual one-on-one meetings with registered investors and pharmaceutical companies throughout the conference. Interested parties should visit https://ibn.fm/hNXn7 to register for the event.
To view the press release, visit: https://ibn.fm/apyHM
About AzurRx BioPharma Inc.
AzurRx BioPharma is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases. The company has a pipeline of three gut-restricted GI assets. The lead therapeutic candidate is MS1819, a recombinant lipase for the treatment of exocrine pancreatic insufficiency (“EPI”) in patients with cystic fibrosis and chronic pancreatitis, currently in two Phase 2 clinical trials. AzurRx is launching two clinical programs using proprietary formulations of niclosamide, a pro-inflammatory pathway inhibitor, FW-420, for grade 1 immune checkpoint inhibitor colitis and diarrhea in oncology patients and FW-1022, for COVID-19 gastrointestinal infections. The company is headquartered in Delray Beach, Florida with clinical operations in Hayward, California. For more information, visit www.AzurRx.com.
NOTE TO INVESTORS: The latest news and updates relating to AZRX are available in the company’s newsroom at http://ibn.fm/AZRX
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
Standard Lithium (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF), an innovative technology and lithium project development company, today announced successful completion of its Arkansas-produced lithium chloride into 99.985% pure lithium carbonate using OEM technology. According to the update, Veolia Water Technologies completed the work at its facility in Plainfield, Illinois, which demonstrates that the lithium chloride intermediate product produced by Standard Lithium’s industrial scale LiSTR Direct Lithium Extraction (“DLE”) plant in Arkansas can be converted into better-than battery quality lithium carbonate using established OEM carbonation technology. “We’ve now demonstrated that we can convert to battery quality lithium carbonate using the company’s SiFT technology; that we can get to the same end-product using established technology developed and sold by global OEMs; and now we’re looking to add battery quality lithium hydroxide to the product offering,” said Dr. Andy Robinson, president and COO of Standard Lithium. “In the background, we continue to rapidly advance both project and corporate development work. We’re excited about reaching the various milestones ahead of us and, if we’re successful, taking this globally important project into commercialization.”
To view the full press release, visit http://ibn.fm/CB3HO
About Standard Lithium Ltd.
Standard Lithium is an innovative technology and lithium development company. The company’s flagship project is located in southern Arkansas, where it is engaged in the testing and proving of the commercial viability of lithium extraction from over 150,000 acres of permitted brine operations. The company has commissioned its first of a kind industrial scale Direct Lithium Extraction Demonstration Plant at LANXESS South Plant facility in southern Arkansas. The Demonstration Plant utilizes the company’s proprietary LiSTR technology to selectively extract lithium from LANXESS’ tailbrine. The Demonstration Plant is being used for proof-of-concept and commercial feasibility studies. The scalable, environmentally friendly process eliminates the use of evaporation ponds, reduces processing time from months to hours and greatly increases the effective recovery of lithium. The company is also pursuing the resource development of over 30,000 acres of separate brine leases located in southwestern Arkansas and approximately 45,000 acres of mineral leases located in the Mojave Desert in San Bernardino County, California.
Standard Lithium is listed on the TSX Venture Exchange under the trading symbol “SLL;” quoted on the OTC – Nasdaq Intl Designation under the symbol “STLHF” and on the Frankfurt Stock Exchange under the symbol “S5L.” For more information, please visit the company’s website at www.StandardLithium.com.
NOTE TO INVESTORS: The latest news and updates relating to STLHF are available in the company’s newsroom at http://ibn.fm/STLHF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced its plans to participate in two virtual investor conferences in the month of March. These include the Sachs 14th Annual European Life Sciences CEO Forum taking place March 10-12, as well as the 33rd Annual Roth Conference scheduled to be held from March 15-17, 2021. The company’s president and CEO, Rodney Varner, will lead Genprex’s presentations and will be available for one-on-one meetings with investors throughout the conferences. Interested parties should visit https://ibn.fm/MUouk and https://ibn.fm/J1qLh to register. The presentations will be available for replay on the company’s website for a period of time following the events.
To view the full press release, visit http://ibn.fm/K4xDf
About Genprex Inc.
Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The company’s lead product candidate, “REQORSA(TM)” (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). REQORSA has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. REQORSA has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for REQORSA for NSCLC in combination therapy with osimertinib (AstraZeneca’s Tagrisso(R)) for patients with EFGR mutations whose tumors progressed after treatment with osimertinib alone. For more information, visit the company’s web site at www.Genprex.com.
NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, has released a shareholder update outlining the company’s stable business development and remarkable performance throughout 2020, as well as several key business milestones that have set the course for what Foresight believes will be a successful year. In addition, the company today announced that its wholly owned subsidiary, Eye-Net Mobile Ltd., successfully completed a controlled trial of its Eye-Net(TM) Protect cellular-based accident prevention solution for the intelligent transport system division of a multi-billion-dollar global Japanese vehicle manufacturer. Blue and White Robotics (“BWR”) supervised the trial that was designed to demonstrate Eye-Net’s advanced capabilities of protecting vehicles from oncoming collisions. “Eye-Net successfully completed another controlled trial and met all predefined objectives and key performance indicators, demonstrating Eye-Net Protect’s system capabilities. The system configuration used in the trial was almost identical to the production configuration, mimicking real-life situations with almost no safety margins,” said Dror Elbaz, COO and deputy CEO of Eye-Net Mobile. ”The test results confirm that the Eye-Net technology and product are ready for commercial deployment and may bring outstanding added value to all road users in general and to the automotive industry in particular.”
To view the full press releases, visit https://ibn.fm/FtBVW and https://ibn.fm/kh4Af
About Foresight Autonomous Holdings Ltd.
Foresight, founded in 2015, is a technology company engaged in the design, development and commercialization of sensors systems for the automotive industry. Through the company’s wholly owned subsidiaries, Foresight Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both “in-line-of sight” vision systems and “beyond-line-of-sight” cellular-based applications. Foresight’s vision sensor is a four-camera system based on 3D video analysis, advanced algorithms for image processing, and sensor fusion. Eye-Net Mobile’s cellular-based application is a V2X (vehicle-to-everything) accident prevention solution based on real-time spatial analysis of clients’ movement.
The company’s systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is targeting the advanced driver assistance systems (“ADAS”), the semi-autonomous and autonomous vehicle markets and predicts that its systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform and advanced technology.
For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit www.ForesightAuto.com
NOTE TO INVESTORS: The latest news and updates relating to FRSX are available in the company’s newsroom at http://ibn.fm/FRSX
About ChineseWire
ChineseWire (CW) is a specialized communications platform focused on promising China-based companies that are listed in North America. As one of 40+ brands within the InvestorBrandNetwork (“IBN”), CW provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution to IBN’s millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, CW is uniquely positioned to best serve private and public Chinese companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CW brings its clients unparalleled visibility, recognition and brand awareness. CW is where news, content and information converge.
For more information, please visit https://www.ChineseWire.com
Please see full terms of use and disclaimers on the ChineseWire website applicable to all content provided by CW, wherever published or re-published: https://www.ChineseWire.com/Disclaimer
ChineseWire
Los Angeles, California
www.ChineseWire.com
310.299.1717 Office
Editor@ChineseWire.com
ChineseWire is part of the InvestorBrandNetwork.
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, will be hosting a conference call and webcast on Tuesday, March 9, 2021, ET. The purpose of the call is for the company to announce its fourth-quarter and fiscal year results. DRIO CEO Erez Raphael, president and general manager of North America Rick Anderson and CFO Zvi Ben-David will host the conference, which is scheduled to begin at 8:30 a.m. ET. Anyone interested in participating can dial in; callers are invited to join 10 minutes before the webcast begins by calling 877-451-6152 (domestic) or 201-389-0879 (international). The call will be available for replay about two hours after the call and will be available through April 9, 2021. The replay can be heard by dialing 844-512-2921 (domestic) or 412-317-6671 (international) and entering the replay passcode 13716928.
To view the webcast, visit http://ibn.fm/oczM6
To view the full press release, visit http://ibn.fm/4u0wV
About DarioHealth Corp.
DarioHealth Corp. is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. Dario’s next-generation, AI-powered, digital therapeutic solutions support more than just an individual’s disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software and coaching to help individuals improve health and sustain meaningful outcomes. Dario offers one of the highest-rated diabetes and hypertension solutions on the market. The company’s cross-functional team operates at the intersection of life sciences, behavioral science, and software technology and is rapidly expanding into new chronic conditions and geographic markets, using a performance-based approach to improve its users’ health. Dario makes the right thing to do the easy thing to do. For more information about the company, please visit www.DarioHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
ANN ARBOR, Mich. , March 1, 2021 — Amesite Inc . (Nasdaq: AMST), an ed-tech, SaaS company with the most advanced artificial intelligence driven online learning platform in the industry, providing both content creation and a best-in-class infrastructure for the multi-billion-dollar online learning markets in business and education, announced today the successful implementation of its whole enterprise solution for The Henry Ford Museum of American Innovation.
Amesite’s cloud-based platform and content creation services provide fully managed, customized, learning environments for business, universities, and K-12 schools. The platform has the capacity to upload an organization’s entire training and educational materials into a single point of access.
CEO and Founder Dr. Ann Marie Sastry , commented, “Being able to bring an entire organization into the Amesite platform is a crucial benchmark for the future of artificial intelligence-backed training and upskilling programs. We developed these solutions and scaled their capacity because we are increasingly hearing from companies that there is a critical need for wholesale improvement in the way they create and deliver content. Businesses and educational institutions are looking for cloud-based solutions that are engaging, easy-to-use, and deliver concrete measurable results, especially now that many companies are dealing with split remote and in-person workforces.”
Addressing a global online education market projected to grow to $319 billion by 2025, Amesite has been rapidly ramping up its capabilities to deliver whole-organization solutions for companies with large-scale educational, training and upskilling needs. It recently launched a complete online learning platform, inHub, for The Henry Ford Museum, an internationally recognized museum with more than 26 million primary and secondary source artifacts and lesson plans that detail more than 300 years of American innovation, ingenuity, and resourcefulness. A video detailing that launch can be found at: https://lp.amesite.com/thf-case-study .
“Initial results indicate that inHub is an unparalleled educational tool,” said Patricia Mooradian , President and CEO of The Henry Ford Museum. “Amesite’s technology has made our system scalable, flexible, and easy-to-use so that we can fully achieve our goals of teaching and inspiring that next generation of innovators and inventors.”
Dr. Sastry further commented, “Providing an organization with the ability to migrate their entire training system into our AI-backed ecosphere is a gamechanger for those needing to provide learning solutions to thousands of employees or students. In just a short time, we have been able to scale our platforms from single courses to a point now that we can bring entire institutions on board quickly and seamlessly.”
ABOUT AMESITE
Amesite is an ed-tech, SaaS company with the most advanced artificial intelligence driven online learning platform in the industry, providing both content creation and a best-in-class infrastructure for the multi-billion-dollar online learning markets in business and education. For more information, visit www.Amesite.com .
Forward Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company’s planned online machine learning platform, the Company’s business plans, any future commercialization of the Company’s online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “plan,” “believe,” “intend,” “look forward,” and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company’s filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investors Contact :
Dave Gentry
RedChip Companies Inc.
1-800-RED-CHIP (733-2447)
Or 407-491-4498
Dave@redchip.com
Amesite (NASDAQ: AMST), an ed-tech, software-as-a-service (“SaaS”) company with the industry’s most advanced artificial intelligence-driven online learning platform, today announced the successful implementation of its whole enterprise solution for the Henry Ford Museum of American Innovation. “Being able to bring an entire organization into the Amesite platform is a crucial benchmark for the future of artificial intelligence-backed training and upskilling programs. We developed these solutions and scaled their capacity because we are increasingly hearing from companies that there is a critical need for wholesale improvement in the way they create and deliver content,” said Amesite CEO and Founder Dr. Ann Marie Sastry. “Businesses and educational institutions are looking for cloud-based solutions that are engaging, easy-to-use, and deliver concrete measurable results, especially now that many companies are dealing with split remote and in-person workforces.”
To view the full press release, visit https://ibn.fm/kpzP3
About Amesite Inc.
Amesite is an ed-tech, software-as-a-service (“SaaS”) company with the most advanced artificial intelligence-driven online learning platform in the industry, providing both content creation and a best-in-class infrastructure for the multibillion online learning markets in business and education. For more information, visit www.Amesite.com.
NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at http://ibn.fm/AMST
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, has provided an update to its Jan. 22, 2021, press release regarding recent promotional and investor relations. The updated comments were made at the request of IIROC and the Canadian Securities Exchange (“CSE”). The comments are specifically in regard to a newsletter published by WallStreetAlerts, on behalf of the company. In addition to the updated comments, the company reminded investors that the best source for full disclosure about the company is the company itself, as well as SEDAR or CSE profile pages for regulatory filings and news releases. The company acknowledges that prior to the date of this news release, XPhyto had not comply with CSE requirements to complete and post Form 10 Notices of Proposed Significant Transactions disclosing its contracts with the third-party providers. The company has now completed and posted all required forms to the CSE and will continue to do so in the future.
To view the full press release, visit: https://ibn.fm/UaAJn
About XPhyto Therapeutics Corp.
XPhyto Therapeutics is a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral-health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications, including psychedelic compounds and cannabinoids. XPhyto has research and development operations in North America and Europe, with an operational focus in Germany, and the company is currently focused on regulatory approval and commercialization of medical products for European markets. For more information about this company, please visit www.XPhyto.com
NOTE TO INVESTORS: The latest news and updates relating to XPHYF are available in the company’s newsroom at http://ibn.fm/XPHYF
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
Legislators in Vermont are planning to introduce no fewer than two measures to decriminalize drug possession this legislative session.
In an interview, State Rep. Brian Cina stated that the bill he plans to introduce would eliminate penalties imposed on a range of fungi and plant-based psychedelics, including DMT, psilocybin, ibogaine and mescaline.
In a press conference, Rep. Selene Colburn stated that a bill she was working on would decriminalize all drugs was being drafted and would be introduced later in the session. Colburn stated that legislators were still working out the model, adding that they would probably use Oregon’s measure as a guide. The state of Oregon decriminalized all drugs through a ballot measure during the November 2020 elections.
Chittenden County state attorney Sarah George stated that drugs weren’t illegal because they were dangerous but being illegal did make them more dangerous. She explained that everything was much safer when it was regulated and legalized, adding that compared to illegal drugs, legal drugs were much safer.
Another measure that’s currently being drafted for the upcoming legislative session could regulate kratom sales and decriminalize buprenorphine. The former is a painkiller alternative and herbal medicine while the latter is utilized as a treatment for opioid use disorder. Cina stated that a separate legislation, dubbed the Kratom Consumer Protection Act, would be used to help regulate sales and legalize the kratom. The legislation would establish a minimum age for purchasing the drug and outline rules that would help ensure product dosage and purity.
While there are those in favor of the decriminalization of all drugs, others oppose measures to do so, arguing that it would be a step too far. Attorney General TJ Donovan recently stated on a podcast that he supported some drug reform policies and acknowledged that drug reform policies could decrease harm. However, he noted that he could not, philosophically speaking, wrap his head around how public health or public safety could be improved by decriminalizing heroin.
Despite this though, Donovan asserted that he was open to ideas such as safe injection sites. He said that people shouldn’t shy away from tough conversations as progress was made, adding that people should be guided by both data and science as they make informed decisions.
Legislators from other states such as Virginia, Kansas, Florida and Connecticut are also considering drug policy and psychedelics reform bills for the 2021 session.
Meanwhile, Canada-headquartered XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) has vowed to press ahead with its 2021 plans of developing psychedelic drug formulations, especially those that will be administered through sublingual or transdermal methods.
NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://ibn.fm/XPHYF
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
Marijuana has been used for many centuries as an aphrodisiac, with early recordings showing its use in India in the seventh century. Presently, many consumers of marijuana claim that the substance improves one’s sex life. At the same time, others claim that marijuana can also affect sex negatively in different ways. However, science has shown that cannabis can improve an individual’s sex life in various ways. We look at them below.
- Marijuana users engage in more sex
Research conducted in 2017 examined survey data collected from roughly 50,000 women and men to see if using marijuana had any influence on how often individuals had sex. They found that people who used marijuana had intercourse more frequently that people who did not. This statement remained unchanged for both women and men in every demographic group. Additionally, the study discovered that the use of marijuana did not diminish sexual function.
- Women who use marijuana have more satisfying orgasms
Research carried out in 2019 found a connection between orgasms in women and marijuana. Researchers in the study surveyed 373 female patients at a gynecological and obstetrics practice and discovered that 127 of them consumed marijuana before engaging in intercourse, which increased their chances of having a satisfactory orgasm compared to women who did not use marijuana. Furthermore, those who consumed marijuana more frequently had higher chances of achieving a satisfying orgasm than those who consumed marijuana on occasion.
- Marijuana connected to better women’s sexual health
A study conducted last year assessed a group of women who consumed marijuana as well as the survey that examined the link between their sexual health and marijuana use. The survey was made up of questions on pain, desire, satisfaction, orgasms, lubrication and arousal; these are factors most commonly used to assess sexual health in females.
The researchers found that women who consumed marijuana often usually scored higher on various sexual health measures, in particular satisfaction, sexual desire, orgasms and arousal. This was in comparison to women who consumed marijuana less frequently.
This remained unchanged regardless of how the weed was consumed or the type of marijuana consumed.
- Marijuana may better men’s erectile function
A 2011 study that reviewed literature on the link between male sexual function and marijuana found inconclusive results with some studies demonstrating negative effects on male sexual health and others finding positive effects, with study authors going as far as concluding that marijuana could possibly boost erectile function. However, more research is needed on this topic.
- Women who use marijuana experience less pain and have a higher sexual urges.
A study carried out in 2017 surveyed 289 women and found that the majority of them admitted to the medicinal plant boosting their interest in sex. An estimated 77% also reported that marijuana use decreased their pain during sex.
Meanwhile, The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) has relied on innovation as well as expansion to grow from making alkaline water to adding a product line of CBD-infused capsules, drinks, tinctures and gummies.
NOTE TO INVESTORS: The latest news and updates relating to The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) are available in the company’s newsroom at http://cnw.fm/WTER
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
- Online sales of new TAAT tobacco-free, nicotine-free option totals CDN$100,000 sales in only five days
- TryTAAT site launched on Feb. 17 with cartons of TAAT Original, Smooth and Menthol available for purchase
- “February has been a very productive month for us here at TAAT,” says CEO, citing list of achievements
Within the first five days of the launch of its e-commerce portal, TAAT Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF) reported that its flagship product — TAAT(TM), a tobacco-free and nicotine-free alternative to traditional cigarettes offered in Original, Smooth and Menthol —had totaled more than CDN$100,000 in sales, with $48,000 of that coming in the first 48 hours (https://ibn.fm/cyc6O). Those numbers confirm what the TAAT team has known since the launch of the product only two months ago: legal-age smokers are eagerly looking for a nicotine- and tobacco-free smoking experience (https://ibn.fm/0mrwU).
A life sciences company committed to providing that kind of smoking experience to adult smokers, TAAT lunched its e-commerce portal last Wednesday at 9 a.m. ET (https://ibn.fm/snLKs). Designed to allow smokers aged 21 years and older to purchase TAAT’s flagship product, the TryTAAT site has delivered beyond what TAAT management expected.
“To sell more than CDN$100,000 worth of a relatively new product in such a short period is absolutely exceptional,” said TAAT CEO Setti Coscarella. “Countless smokers aged 21-plus in the United States have been eagerly awaiting the launch of our online store on Wednesday, which I believe has contributed significantly to our product sales this past week.”
The site launched on Wednesday, with cartons of TAAT Original, Smooth and Menthol available for purchase by adult-age smokers and shipment to addresses in eligible jurisdictions. Shortly after the initial launch, a Taste Explorer Bundle was added to the site, consisting of one 20-stick pack of each of the three TAAT varities. In addition, the company’s TryTAATpromotion remains active, in which adult smokers in eligible states can request a complimentary sample pack of the TAAT variety of their choice.
TAAT is pioneering a new concept with TAAT, its tobacco-free and nicotine-free smoking alternative. TAAT’s base material is Beyond Tobacco, a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. TAAT products were first unveiled in various retail locations throughout Ohio, where an estimated 60% of retailers who carried the product for at least three weeks have reordered at least once (https://ibn.fm/9W75P).
“Our iterative rollout of TAAT in the United States has been very strategically planned to test the initial reactions of smokers aged 21-plus when introduced to the concept of a nicotine-free and tobacco-free smoking experience, while also gauging reception of the product after it is sampled for the first time,” said Coscarella. “Over the past two months, we have had the opportunity to gather quite a bit of feedback about TAAT from smokers aged 21-plus as well as retailers and wholesalers of tobacco. I believe those insights have proven useful, as they played a role in creating our strategies for launching the TAAT online store on Wednesday, which has been a remarkable success so far. . . .
“February has been a very productive month for us here at TAAT,” he continued. “In addition to launching our e-commerce portal and selling over CDN$50,000 worth of TAAT in 48 hours, we also secured our engagement with a major CPG sales agency, landed our first mainstream nationwide media coverage in ‘Forbes,’ and boosted our manufacturing rate by 233%. All of our initiatives for bringing TAAT to market in the United States are strategically coordinated, and I believe that e-commerce plays a significant role in providing us the opportunity to sell TAAT to smokers aged 21+ all across the United States while complementing our Ohio retail activities and a nationwide rollout with the CPG sales agency set to begin next week.”
Under executive leadership with Big Tobacco pedigree, TAAT was launched in the United States in Q4 2020 and is focused on positioning itself in the $814 billion global tobacco industry.
For more information, visit the company’s website at www.TAATGlobal.com.
NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
TAAT(TM) Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2), a life sciences company dedicated to giving legal-aged smokers the choice to keep the smoking experience that they enjoy with no nicotine and no tobacco, announced plans to expand into Canada with its recently signed memorandum of understanding (“MOU”). The agreement with Christina Lake Cannabis Corp. (CSE: CLC) outlines a partnership between the two companies to develop and distribute TAAT(TM) for the Canadian market. According to the MOU, CLC will have exclusive rights to develop and distribute TAAT in Canada for a two-year renewable time period. In the announcement, TAAT noted that considerable interest for its products exists in Canada, which has a population of more than 37 million, even though the company has not done any product marketing there. Through its existing licenses, CLC can procure hemp biomass from third-party growers, produce TAAT’s Beyond Tobacco base material, and then manufacture and distribute TAAT through authorized wholesale and retail channels across Canada. “We are very pleased to have partnered with CLC, giving us the opportunity to bring TAAT to legal-aged smokers in Canada, many of whom have shown great enthusiasm about the product,” said TAAT CEO Setti Coscarella in the press release. “During my time in the tobacco industry, it was widely known that Canada was an exceptionally complex region in which to do business because of challenging regulations. Likewise, for products such as TAAT, which utilize hemp, the licensing requirements frequently represent a barrier to entry, often requiring products to be made or distributed through a Licensed Producer such as CLC. We have contemplated several international markets to which TAAT could expand first, and I believe that Canada is the ideal play based on the existing interest we already have from legal-aged smokers across Canada, a positive relationship with CLC to develop and distribute the product on our behalf, and a marketplace where the affordable price point of TAAT adds to its value proposition as a better choice.”
To view the full press release, visit http://ibn.fm/dmNq7
About TAAT Lifestyle & Wellness Ltd.
TAAT Lifestyle and Wellness has developed TAAT, which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in Original, Smooth and Menthol varieties. TAAT’s base material is Beyond Tobacco(TM), a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with Big Tobacco pedigree, TAAT was launched first in the United States in Q4 2020 as the company seeks to position itself in the $814 billion global tobacco industry. For more information, please visit www.TAATGlobal.com.
NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at http://ibn.fm/TOBAF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
